Large-scale testing (Phase 3)Study completedNCT02117453
What this trial is testing
Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides
Who this might be right for
ANCA-associated Primary Necrotizing Vasculitides
Assistance Publique - Hôpitaux de Paris 121